The development of high-throughput omics technologies represents an unmissable opportunity for evidence-based prevention of adverse effects on human health. However, the applicability and access to multi-omics tests are still limited also in developed countries. Main obstacles are the rapid increase of knowledge, the high level of necessary expertise - especially for big-data base validation and elaboration -and requested economic investment. The microbiome research is included in such context, as one of the last omics frontiers. Microbiome play an important role in human biology and disease. Much has been done to explore its diversity in early onset of disease and during disease progression while a full understanding of human microbiomes demands also an evolutionary perspective at a population level. The high quantity of evidences produced in a relative short time by the scientific community shows an effective improvement perspective for human disease prevention and public health purpose. The evaluation of the stability of healthy microbiota variations during the time under an evolutionary point of view can consolidate such opportunity.
For the last few decades, the scientific interests across the globe are increasing the interaction, the health impact, the preventive opportunities of microbiomics including in the other omics sciences to improve human health. However, the implementation of such analytic perspective is not so wide in the common preventive proposal to the population. Therefore, this Research Topic aims to highlight original research and reviews exploring how an effective population health gain is possible if omics tools are implemented for each person after a preliminary assessment of effectiveness in the medium and then long term.
We welcome articles on the omics studies and strategies integration in disease prevention and for environmental and sustainable health, under a One Health point of view of Public Health, including microbiome data, considering an exposome approach or discussing effectiveness preventive research studies.
For the last few decades, the scientific interests across the globe are increasing the interaction, the health impact, the preventive opportunities of microbiomics including in the other omics sciences to improve human health. However, the implementation of such analytic perspective is not so wide in the common preventive proposal to the population. One of the knowledge gap is the inclusion of data without evolutionary history, useful to highlight host-microbiota interaction during the time at a population level. Therefore, this Research Topic aims to highlight original research and reviews exploring how an effective population health gain is possible if omics tools are implemented for each person after a preliminary assessment of effectiveness in the medium and then long term, selecting the evidence supported also under an evolutionary point of view.
We welcome articles focusing on but not limited to:
(1) Public Health omics applications;
(2) omics strategies integration in disease prevention;
(3) evolutionary microbiome analysis for environmental and sustainable health;
(4) exposome studies under a One Health point of view of Public Health, including microbiome data discussing effectiveness preventive research studies.
The development of high-throughput omics technologies represents an unmissable opportunity for evidence-based prevention of adverse effects on human health. However, the applicability and access to multi-omics tests are still limited also in developed countries. Main obstacles are the rapid increase of knowledge, the high level of necessary expertise - especially for big-data base validation and elaboration -and requested economic investment. The microbiome research is included in such context, as one of the last omics frontiers. Microbiome play an important role in human biology and disease. Much has been done to explore its diversity in early onset of disease and during disease progression while a full understanding of human microbiomes demands also an evolutionary perspective at a population level. The high quantity of evidences produced in a relative short time by the scientific community shows an effective improvement perspective for human disease prevention and public health purpose. The evaluation of the stability of healthy microbiota variations during the time under an evolutionary point of view can consolidate such opportunity.
For the last few decades, the scientific interests across the globe are increasing the interaction, the health impact, the preventive opportunities of microbiomics including in the other omics sciences to improve human health. However, the implementation of such analytic perspective is not so wide in the common preventive proposal to the population. Therefore, this Research Topic aims to highlight original research and reviews exploring how an effective population health gain is possible if omics tools are implemented for each person after a preliminary assessment of effectiveness in the medium and then long term.
We welcome articles on the omics studies and strategies integration in disease prevention and for environmental and sustainable health, under a One Health point of view of Public Health, including microbiome data, considering an exposome approach or discussing effectiveness preventive research studies.
For the last few decades, the scientific interests across the globe are increasing the interaction, the health impact, the preventive opportunities of microbiomics including in the other omics sciences to improve human health. However, the implementation of such analytic perspective is not so wide in the common preventive proposal to the population. One of the knowledge gap is the inclusion of data without evolutionary history, useful to highlight host-microbiota interaction during the time at a population level. Therefore, this Research Topic aims to highlight original research and reviews exploring how an effective population health gain is possible if omics tools are implemented for each person after a preliminary assessment of effectiveness in the medium and then long term, selecting the evidence supported also under an evolutionary point of view.
We welcome articles focusing on but not limited to:
(1) Public Health omics applications;
(2) omics strategies integration in disease prevention;
(3) evolutionary microbiome analysis for environmental and sustainable health;
(4) exposome studies under a One Health point of view of Public Health, including microbiome data discussing effectiveness preventive research studies.
